Search

everythinglearnresearchcommunity

for

Search:↓

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Detailed history and physical examination are crucial for diagnosing hair loss.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Permanent hair dye may cause total hair loss.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.